These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28087925)

  • 21. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE; Smith SN; Johnson AO; DeOrnellas V; Eaton KA; Yep A; Mody L; Wu W; Mobley HLT
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial adherence in the pathogenesis of urinary tract infection: a review.
    Reid G; Sobel JD
    Rev Infect Dis; 1987; 9(3):470-87. PubMed ID: 2885910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper Is a Host Effector Mobilized to Urine during Urinary Tract Infection To Impair Bacterial Colonization.
    Hyre AN; Kavanagh K; Kock ND; Donati GL; Subashchandrabose S
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of bacteriuria and infection in the spinal cord injured patient.
    Siroky MB
    Am J Med; 2002 Jul; 113 Suppl 1A():67S-79S. PubMed ID: 12113873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and Characterization of UTI and CAUTI in a Mouse Model.
    Conover MS; Flores-Mireles AL; Hibbing ME; Dodson K; Hultgren SJ
    J Vis Exp; 2015 Jun; (100):e52892. PubMed ID: 26132341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract.
    Bergsten G; Wullt B; Svanborg C
    Int J Med Microbiol; 2005 Oct; 295(6-7):487-502. PubMed ID: 16238023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.
    Garofalo CK; Hooton TM; Martin SM; Stamm WE; Palermo JJ; Gordon JI; Hultgren SJ
    Infect Immun; 2007 Jan; 75(1):52-60. PubMed ID: 17074856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli.
    Tseng CC; Wu JJ; Liu HL; Sung JM; Huang JJ
    Am J Kidney Dis; 2002 Apr; 39(4):744-52. PubMed ID: 11920340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Virulence factors and host responses in urinary tract infections].
    Matsumoto T
    J UOEH; 1998 Mar; 20(1):45-60. PubMed ID: 9551528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity.
    Nienhouse V; Gao X; Dong Q; Nelson DE; Toh E; McKinley K; Schreckenberger P; Shibata N; Fok CS; Mueller ER; Brubaker L; Wolfe AJ; Radek KA
    PLoS One; 2014; 9(12):e114185. PubMed ID: 25486068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host parasite interaction in urinary tract infection.
    Svanborg-Edén C; de Man P; Jodal U; Linder H; Lomberg H
    Pediatr Nephrol; 1987 Oct; 1(4):623-31. PubMed ID: 3153343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasion of Host Cells and Tissues by Uropathogenic Bacteria.
    Lewis AJ; Richards AC; Mulvey MA
    Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28087946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity.
    Goneau LW; Hannan TJ; MacPhee RA; Schwartz DJ; Macklaim JM; Gloor GB; Razvi H; Reid G; Hultgren SJ; Burton JP
    mBio; 2015 Mar; 6(2):. PubMed ID: 25827417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgens Enhance Male Urinary Tract Infection Severity in a New Model.
    Olson PD; Hruska KA; Hunstad DA
    J Am Soc Nephrol; 2016 Jun; 27(6):1625-34. PubMed ID: 26449605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical implications of bacterial pathogenesis and mucosal immunity in chronic urinary tract infection.
    Chieng CCY; Kong Q; Liou NSY; Khasriya R; Horsley H
    Mucosal Immunol; 2023 Feb; 16(1):61-71. PubMed ID: 36642381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
    mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Murine Model for Escherichia coli Urinary Tract Infection.
    Hannan TJ; Hunstad DA
    Methods Mol Biol; 2016; 1333():159-75. PubMed ID: 26468108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predisposing to urinary tract infections in children.
    Roberts JA
    Pediatr Nephrol; 1996 Aug; 10(4):517-22. PubMed ID: 8865259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do type 1 fimbriae promote inflammation in the human urinary tract?
    Bergsten G; Wullt B; Schembri MA; Leijonhufvud I; Svanborg C
    Cell Microbiol; 2007 Jul; 9(7):1766-81. PubMed ID: 17359236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.